A Phase 2, Open Label Study of Dalantercept plus Sorafenib in Patients with Advanced Hepatocellular Carcinoma - Regional Cancer Care Associates LLC

Clinical Trials

A Phase 2, Open Label Study of Dalantercept plus Sorafenib in Patients with Advanced Hepatocellular Carcinoma

Type of Cancer
Gastrointestinal
Locations
Hackensack
Sponsor
Acceleron
Protocol Number
A041-05
Cancer Diagnosis
To Learn More Call
201-510-0910